Home Differentiating transudative from exudative pleural effusion: should we measure effusion cholesterol dehydrogenase?
Article
Licensed
Unlicensed Requires Authentication

Differentiating transudative from exudative pleural effusion: should we measure effusion cholesterol dehydrogenase?

  • Mathie P.G. Leers , Henne A. Kleinveld and Volkher Scharnhorst
Published/Copyright: October 10, 2007
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 45 Issue 10

Abstract

Introduction: Pleural effusions are often classified into transudates and exudates based on Light's criteria. In this study, the diagnostic properties of Light's criteria were compared to those of several other analytes for the classification of pleural fluids into transudative and exudative.

Methods: A total of 471 patients with pleural effusions were evaluated. In pleural effusions and simultaneously drawn blood samples, lactate dehydrogenase (LDH), total protein, albumin, cholesterol, amylase, glucose, pH and the cell number were measured. Retrospectively, the clinical records were used to establish a clinical diagnosis. The diagnostic properties of the biochemical tests were calculated using the clinical diagnoses as gold standard.

Results: By clinical diagnosis, 108 patients had transudative and 300 patients had exudative pleural effusions. In addition to pleural LDH activity (accuracy 89%, sensitivity 86%, specificity 97%) and fluid to serum LDH ratio (accuracy 89%, sensitivity 91%, specificity 85%), pleural cholesterol concentration readily identified exudates (accuracy 82%, sensitivity 76%, specificity 98%). Combination of these three parameters achieved a higher overall accuracy (accuracy 95%, sensitivity 93%, specificity 100%) than the Light's criteria (accuracy 93%, sensitivity 100%, specificity 73%). Combination of effusion cholesterol concentration and effusion LDH activity had the highest discriminatory potential (accuracy 98%, sensitivity 98%, specificity 95%).

Conclusions: Including effusion cholesterol, concentration in the routine biochemical work-up of pleural fluid allows for correct classification of more pleural effusions than achieved by use of Light's criteria. Combination of cholesterol and LDH had the highest discriminatory potential and the added advantage that no patient plasma is needed for correct classification.

Clin Chem Lab Med 2007;45:1332–8.


Corresponding author: Mathie P.G. Leers, PhD, Department of Clinical Chemistry and Hematology, Atrium Medical Center Parkstad, P.O. Box 4446, 6401 Heerlen, The Netherlands Phone: +31-45-5767503, Fax: +31-45-5766255,

Received: 2007-3-9
Accepted: 2007-6-12
Published Online: 2007-10-10
Published in Print: 2007-10-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Atrial natriuretic peptide and related peptides
  2. The −374A allele of the receptor for advanced glycation end products (RAGE) gene promoter is a protective factor against cardiovascular lesions in type 2 diabetes mellitus patients
  3. Biochemical properties of endogenous presenilin 1 and presenilin 2 in cultured human B-lymphocytes
  4. CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population
  5. Preservation of RNA for functional analysis of separated alleles in yeast: comparison of snap-frozen and RNALater® solid tissue storage methods
  6. Mother-child double incompatibility at vWA and D5S818 loci in paternity testing
  7. Matrix metalloprotease-2 and -9 concentration and activity in serum and culture medium samples: a methodological reappraisal
  8. Are changes in blood-ethanol concentration during storage analytically significant? Importance of method imprecision
  9. Measurement of arginine derivatives in pediatric patients with chronic kidney disease using high-performance liquid chromatography-tandem mass spectrometry
  10. The soluble transferrin receptor reflects tumor load in chronic lymphocytic leukemia
  11. Calculated low-density lipoprotein cholesterol remains a viable and important test for screening and targeting therapy
  12. Angiotensin-converting enzyme (ACE) I/D corrected serum ACE activity and severity assessment of community-acquired pneumonia
  13. Differentiating transudative from exudative pleural effusion: should we measure effusion cholesterol dehydrogenase?
  14. Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort
  15. Cytokines and growth factors in mostly atherosclerotic patients on hemodialysis determined by biochip array technology
  16. Use of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity
  17. High plasma levels of tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8) characterize patients prone to ventricular fibrillation complicating myocardial infarction
  18. Methylprednisolone, cortisol and the cell-mediated immune response in children after ventricular septal defect repair
  19. Standardization of γ-glutamyltransferase assays by intermethod calibration. Effect on determining common reference limits
  20. The effect of endurance exercise-induced lactacidosis on biochemical markers of bone turnover
  21. Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variation
  22. Diagnostic usefulness of a third-generation anti-cyclic citrulline antibody test in patients with recent-onset polyarthritis
  23. Clinical significance of the laboratory determination of low serum copper in adults
  24. National survey on critical values reporting in a cohort of Italian laboratories
  25. Influence of haemodialysis on the NT-proBNP plasma concentration
  26. C–588T polymorphism of the human glutamate-cysteine ligase modifier subunit gene is not associated with the risk and extent of ischemic heart disease in a German cohort
  27. Has homocysteine shrunk?
Downloaded on 30.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2007.285/html
Scroll to top button